Matrix Metalloproteinase Expression in the Recurrence of Superficial Low Grade Bladder Transitional Cell Carcinoma

Journal of Urology

Volumn 177, Issue 3, 2007, Pages 1174-1178

  Choi, Young Deuk ^a   Cho, Nam Hoon ^b   Ahn, Hyun Soo ^d   Cho, Kang Su ^a   Cho, Soung Yong ^a   Yang, Won Jae ^c  

^a Urological Science Institute   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Ajou University School of Medicine   (South Korea)

Author keywords

bladder; carcinoma; local; matrix metalloproteinases; microarray analysis; neoplasm recurrence; transitional cell

Indexed keywords

COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; PROTEIN FOS; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER TISSUE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOLECULE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; UPREGULATION; VALIDITY; WESTERN BLOTTING;

AGED; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846811731     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.10.031     Document Type: Article

References (20)

1. Curran S., and Murray G.I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36 (2000) 1621
2. Murray G.I. Matrix metalloproteinases: a multifunctional group of molecules. J Pathol 195 (2001) 135
3. Kim S., Park H.S., Son H.J., and Moon W.S. The role of angiostatin, vascular endothelial growth factor, matrix metalloproteinase 9 and 12 in the angiogenesis of hepatocellular carcinoma. Korean J Hepatol 10 (2004) 62
4. Moses M.A. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 15 (1997) 180
5. Durkan G.C., Nutt J.E., Rajjayabun P.H., Neal D.E., Lunec J., and Mellon J.K. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder. Clin Cancer Res 7 (2001) 3450
6. Gakiopoulou H., Nakopoulou L., Siatelis A., Mavrommatis I., Panayotopoulou E.G., Tsirmpa I., et al. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas. Clin Cancer Res 9 (2003) 5573
7. Gerhards S., Jung K., Koenig F., Daniltchenko D., Hauptmann S., Schnorr D., et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 57 (2001) 675
8. Hara I., Miyake H., Hara S., Arakawa S., and Kamidono S. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. J Urol 165 (2001) 1769
9. Durkan G.C., Nutt J.E., Marsh C., Rajjayabun P.H., Robinson M.C., Neal D.E., et al. Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer. Clin Cancer Res 9 (2003) 2576
10. Papathoma A.S., Petraki C., Grigorakis A., Papakonstantinou H., Karavana V., Stefanakis S., et al. Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer. Anticancer Res 20 (2000) 2009
11. Sumi T., Yoshida H., Hyun Y., Yasui T., Matsumoto Y., Hattori K., et al. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder. Oncol Rep 10 (2003) 345
12. Xu K., Hou S., and Du Z. Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma. Chin Med J (Engl) 115 (2002) 743
13. Nakopoulou L., Gakiopoulou H., Zervas A., Giannopoulou I., Constantinides C., Lazaris A.C., et al. MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival. Appl Immunohistochem Mol Morphol 9 (2001) 130
14. Kerkela E., Ala-Aho R., Jeskanen L., Rechardt O., Grenman R., Shapiro S.D., et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 114 (2000) 1113
15. Kerkela E., Ala-aho R., Klemi P., Grenman S., Shapiro S.D., Kahari V.M., et al. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 198 (2002) 258
16. Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 161 (1998) 6845
17. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53 (1993) 288
18. Owen J.L., Iragavarapu-Charyulu V., Gunja-Smith Z., Herbert L.M., Grosso J.F., and Lopez D.M. Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 171 (2003) 4340
19. Duivenvoorden W.C., Hirte H.W., and Singh G. Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells. Clin Exp Metastasis 17 (1999) 27
20. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163